Tao Wang
Impact in
-
- Andrographolide Research and Applications
- Pollution top 10%
- Energy and Environment Impacts
Papers in
-
- Animal Disease Management and Epidemiology 6
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Peter A. Simmons (1 shared paper)Pasquale Aragona (1 shared paper)Zhongqiu Liu (2 shared papers)Lan Yu Tang (2 shared papers)Aiqing Li (1 shared paper)Hongbo Zhou (1 shared paper)Ling Ye (1 shared paper)Zhijie Zheng (1 shared paper)
- Journals
- Frontiers in Immunology (4 papers)Scientific Reports (3 papers)Frontiers in Microbiology (3 papers)Angewandte Chemie International Edition (3 papers)Journal of Colloid and Interface Science (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Tao Wang
200 papers receiving 2.5k citations
Tao Wang's Hit Papers
Peers
Comparison fields: 5 of 156
- Complementary and alternative medicine 112
- Pollution 117
- Pharmaceutical Science 65
- Epidemiology 239
- Drug Discovery 2
Countries citing papers authored by Tao Wang
This map shows the geographic impact of Tao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Wang more than expected).
Fields of papers citing papers by Tao Wang
This network shows the impact of papers produced by Tao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Wang. The network helps show where Tao Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Tao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 226 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study Hit paper breakdown → | 2023 | 179 |
| 2 | 2011 | 135 | |
| 3 | 2020 | 106 | |
| 4 | 2019 | 85 | |
| 5 | 2017 | 79 | |
| 6 | 2024 | 70 | |
| 7 | Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China Hit paper breakdown → | 2024 | 66 |
| 8 | 2020 | 58 | |
| 9 | 2021 | 58 | |
| 10 | 2020 | 55 | |
| 11 | 2022 | 53 | |
| 12 | 2017 | 46 | |
| 13 | 2024 | 46 | |
| 14 | 2011 | 42 | |
| 15 | 2015 | 40 | |
| 16 | 2021 | 39 | |
| 17 | 2020 | 38 | |
| 18 | 2022 | 37 | |
| 19 | 2024 | 33 | |
| 20 | Decoding the WHO Global Tuberculosis Report 2024: A Critical Analysis of Global and Chinese Key Data Hit paper breakdown → | 2025 | 32 |
About Tao Wang
Tao Wang is a scholar working on Agronomy and Crop Science, Hepatology, Public Health, Environmental and Occupational Health, Epidemiology and Pulmonary and Respiratory Medicine, having authored 226 papers that have together received 2.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Animal Disease Management and Epidemiology (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Electrocatalysts for Energy Conversion (4 papers), Dialysis and Renal Disease Management (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Breast Cancer Treatment Studies (4 papers) and Sperm and Testicular Function (3 papers). The work is most often cited by research in Complementary and alternative medicine (112 citations), Pollution (117 citations), Pharmaceutical Science (65 citations), Epidemiology (239 citations) and Drug Discovery (2 citations). Tao Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Peter A. Simmons, Pasquale Aragona, Zhongqiu Liu, Lan Yu Tang, Aiqing Li, Hongbo Zhou, Ling Ye, Zhijie Zheng, Zhen Yang and Ming Hu. Their work appears in journals such as Frontiers in Immunology, Scientific Reports, Frontiers in Microbiology, Angewandte Chemie International Edition and Journal of Colloid and Interface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.